Does Bovine Lactoferrin Prevent Death Or Disability In Very Low Birthweight Infants? Childhood Follow Up In The NHMRC LIFT Study
Funder
National Health and Medical Research Council
Funding Amount
$1,474,012.00
Summary
Our international consortium of investigators proposes to undertake follow up in survivors among 1,500 very low birth weight preterm infants enrolled in the NHMRC Lactoferrin Infant Feeding Trial, which is designed to evaluate whether low-cost oral lactoferrin supplementation reduces death and disability in early childhood.
Docosahexaenoic Acid For The Reduction Of Bronchopulomonary Dysplasia In Preterm Infants Born At Less Than 29 Weeks Gestational Age: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,929,854.00
Summary
A major challenge in the care of very preterm babies, is dealing with the fact that the baby has very immature lungs. They are prone to an inflammatory condition known as BPD (broncho-pulmonary dysplasia) that prevents an infant from breathing, much like asthma in older children. This can result in poor health outcomes for life. Our study will test the effect of the omega 3 fat known as DHA in reducing this inflammation in the lung and result in better outcomes for the baby.